James F. Mrazek
Keine laufenden Positionen mehr
Ursprung des Netzwerks ersten Grades von James F. Mrazek
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 1984 and is headquartered in Marlborough, MA.
56
| Subsidiary | Pharmaceuticals: Major | 56 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von James F. Mrazek
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| KALA BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Compliance Officer President Corporate Officer/Principal | |
| PULMATRIX, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman Director/Board Member | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| College of the Holy Cross (Massachusetts) | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| OLD API WIND-DOWN LTD. | Pharmaceuticals: Major | President Chief Executive Officer Compliance Officer | |
| POZEN INC. | Pharmaceuticals: Major | President Chief Executive Officer Compliance Officer | |
| AUXILIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Administrative Officer Chief Executive Officer Corporate Officer/Principal | |
KOS Pharmaceuticals, Inc.
 KOS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KOS Pharmaceuticals, Inc. operates as pharmaceutical company that developed and commercialized proprietary prescription products for the treatment of chronic cardiovascular, metabolic and respiratory diseases. The company is founded by Daniel M. Bell and Michael Jaharis in 1988 and is headquartered in Cranbury, NJ. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Corporate Officer/Principal | |
MAP Pharmaceuticals LLC
 MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| VERASTEM, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Bionevia Pharmaceuticals, Inc.
 Bionevia Pharmaceuticals, Inc. Hospital/Nursing ManagementHealth Services Bionevia Pharmaceuticals, Inc. operates as a chronic disease hospital. Timothy Joseph Barberich has been the CEO of the American company since 2008. | Hospital/Nursing Management | Chief Executive Officer Director of Finance/CFO | |
| SANTHERA PHARMACEUTICALS HOLDING AG | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer | |
| Babson College | College/University | Masters Business Admin Masters Business Admin | |
| IPI LEGACY LIQUIDATION CO | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Neurovance, Inc.
 Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Founder Chief Operating Officer | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| TSCAN THERAPEUTICS, INC. | Biotechnology | Chairman Chief Executive Officer | |
| NEUROCRINE BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Administrative Officer Director/Board Member | |
| University of Virginia | College/University | Doctorate Degree Doctorate Degree | |
| Wesleyan University | College/University | Undergraduate Degree Doctorate Degree | |
| CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| University of Vermont | College/University | Undergraduate Degree Doctorate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree | |
Vyera Pharmaceuticals LLC
 Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| RESPIRERX PHARMACEUTICALS INC. | Pharmaceuticals: Major | President President | |
| OPKO HEALTH, INC. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer Sales & Marketing | |
| WAVE LIFE SCIENCES LTD. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
ArTara Subsidiary, Inc.
 ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| PROTARA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Founder | |
| NEUROLOGIX, INC. | Internet Software/Services | President Chief Executive Officer | |
| Rensselaer Polytechnic Institute | College/University | Undergraduate Degree Undergraduate Degree | |
| GI DYNAMICS, INC. | Medical Specialties | Director of Finance/CFO Director/Board Member | |
BioSphere Medical, Inc.
 BioSphere Medical, Inc. Medical SpecialtiesHealth Technology BioSphere Medical, Inc. develops, manufactures and markets microsphere technology to medical applications. The company uses microsphere technology to develop its products for medical applications using embolotherapy techniques. It offers Embosphere Microspheres for uterine fibroids, hypervascularized tumors and other arteriovenous malformations, EmboGold Microspheres for Hypervascularized tumors and arteriovenous malformations, EmboCath Infusion Catheter and Segway Guidewire for peripheral embolization procedures and HepaSphere Microspheres for liver cancer. The company was founded in 1993 and is headquartered in Rockland, MA. | Medical Specialties | Director/Board Member Chairman | |
| CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| CORREVIO PHARMA CORP. | Pharmaceuticals: Major | Chairman Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 44 |
| Kanada | 4 |
| Vereinigtes Königreich | 3 |
| Schweiz | 2 |
| Singapur | 2 |
Sektoral
| Health Technology | 39 |
| Consumer Services | 7 |
| Health Services | 3 |
| Commercial Services | 3 |
| Finance | 2 |
Operativ
| Director/Board Member | 206 |
| Corporate Officer/Principal | 100 |
| Chief Tech/Sci/R&D Officer | 64 |
| Independent Dir/Board Member | 60 |
| President | 50 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Mark Corrigan | 29 |
| Timothy Barberich | 28 |
| Mark Iwicki | 26 |
| Timothy James Rink | 23 |
| Robert J. Cresci | 22 |
| Trevor Phillips | 20 |
| Curtis Lockshin | 20 |
| David Southwell | 19 |
| Adrian Adams | 19 |
| Jim O'Shea | 16 |
| Andrew Koven | 16 |
| James W. Young | 15 |
| Lisa Ricciardi | 15 |
| David Hastings | 12 |
| Donna Grogan | 12 |
- Börse
- Insiders
- James F. Mrazek
- Unternehmensverbindungen
